Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer/site revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision v3.5.2 was added; Revision v3.5.0 was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a system version update and does not modify study data or page content.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision history updated: added entry v3.4.3 and removed entry v3.4.2 to reflect the latest submission.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 was added to the history; the government funding lapse notice and the v3.4.1 revision entry were removed.SummaryDifference0.8%

- Check83 days agoChange DetectedThe page history shows a government funding notice being added and a revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.